Riskpilot← Back to searchSign inGet full accessPOLYPEPTIDE LABORATORIES A/S
A/SActiveCVR 19056201Herredsvejen 2Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 19960 employees
Revenue 2024
—
EBITDA margin
—
+45% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK 7,1M
+119% vs 2023
| Revenue | — | — |
| EBITDA | DKK -36K | +45% |
| Net profit | DKK 7,1M | +119% |
| Total assets | DKK 72,9M | +11% |
| Equity | DKK 72,9M | +11% |
| Employees | 0 | — |
Legal name
POLYPEPTIDE LABORATORIES A/S
CVR number
19056201
Legal form
Aktieselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
1. januar 1996
Share capital
DKK 20.000.000
Employees
0
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem eller af et bestyrelsesmedlem i forening med en direktør
Company purpose
Selskabets formål er fabrikation og handel samt at drive virksomhed på områderne udvikling, produktion, distribution og salg af peptider
Address
Herredsvejen 2
Phone
+4548207000
Email
ppl@polypeptide.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.605 | 36.563 | — | 15.200 | 721 | 0 | 24 | 0 | — | — | — | — |
| Staff expenses | -20.409 | -19.282 | -20.797 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 9.712 | 32.628 | 2.904 | -472 | 428 | -42 | -21 | -52 | -61 | -39 | -65 | -36 |
| Depreciation & amort. | -2.387 | -2.292 | -2.897 | -396 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 7.325 | 30.336 | 7 | -868 | 428 | -42 | -21 | -52 | -61 | -39 | -65 | -36 |
| Net financials | -712 | -1.985 | 437 | -2.446 | -1.185 | -1.440 | -803 | 1.326 | -778 | -2.994 | 3.294 | 4.273 |
| Profit before tax | 6.613 | 22.625 | -8.824 | -3.314 | -757 | -1.482 | -824 | 1.274 | -839 | -3.033 | 3.229 | 4.237 |
| Tax | 1.674 | 5.551 | 634 | 7 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -2.823 |
| Net profit | 4.939 | 17.074 | -9.458 | -3.321 | -757 | -1.482 | -824 | 1.274 | -839 | -3.033 | 3.229 | 7.060 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 65.063 | 101.906 | 92.088 | 68.674 | 67.634 | 66.035 | 65.210 | 66.494 | 65.657 | 62.614 | 65.843 | 72.888 |
| Equity | 57.326 | 74.400 | 64.942 | 68.239 | 67.482 | 66.000 | 65.176 | 66.450 | 65.611 | 62.578 | 65.807 | 72.867 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7.737 | 27.460 | 20.526 | 435 | 152 | 35 | 34 | 44 | 46 | 36 | 36 | 21 |
| Total debt | 7.737 | 27.460 | 20.526 | 435 | 152 | 35 | 34 | 44 | 46 | 36 | 36 | 21 |
EBITDA margin
-3600000.0%
This company
15.8%
Market median
-22784910% vs market
20132024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20132024
Return on equity
9.7%
This company
18.4%
Market median
-47% vs market
20132024
Net profit margin
706000000.0%
This company
8.1%
Market median
+8716049283% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MF Management | Management | 2025 | — | — |
JM Management | Management | 2021 | — | — |
AJ Management | Management | 1996 | — | — |
AS Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
ET | Audit | 1996 | — | — |
ET Management | Management | 1996 | — | — |
ES Audit | Audit | 1996 | — | — |
JF Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
JF Management | Management | 2003 | — | — |
RB Management | Management | 2026 | — | — |
PE Management | Management | 1996 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 1996 | — | — | |
| Chairman | 1996 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2003 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 1996 | — | — | |
| Board of Directors | 2003 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
| Individual | 100.0% | 100.0% | 1996 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of POLYPEPTIDE LABORATORIES A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marc Friedrich Augustin | Management | 0 companies |
| Jan Miller | Management | 0 companies |
| Anders Jørgen Hauge Andersen | Management | 0 companies |
| Alain Scarso | Chief Executive Officer | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Erik Thorkild Buhl Lorentsen | Management | 0 companies |
| Erling Stæhr Lohse | Audit | 0 companies |
| Jens Fricke | Chief Executive Officer | 0 companies |
| Jan-Åke Froborg | Management | 0 companies |
| Raoul Bernhardt | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Ole Kjerulf-Jensen | Board of Directors | 0 companies |
| Folke Flateland | Board of Directors | 0 companies |
| Eva Wolf Paulsen | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Chairman | 0 companies |
| Juan José Gonzalez Casanova | Chairman | 0 companies |
| Daniel Gérard M. Lasanow | Board of Directors | 0 companies |
| Jane Anne Salik | Chairman | 0 companies |
| Raymond De Vré | Chairman | 0 companies |
| Dag Frederik Arfst Paulsen | Board of Directors | 0 companies |
| Christina Ellen Del Vecchio | Board of Directors | 0 companies |
| Mats Lundwall | Board of Directors | 0 companies |
| Hans Christian Galst | Board of Directors | 0 companies |
| Lars Göran Peter Nilsson | Board of Directors | 0 companies |